title: [Cost of medical treatment with methotrexate for ectopic pregnancy. Study comparing medical treatment versus laparoscopy. Experience of Aziza Othmana Hospital].
abstract: BACKGROUND
  The ectopic pregnancy can be treated surgically (conservative or radical) or medically. Currently, the choice between medical and surgical treatment is a critical issue. One of the parameters of this choice is the total cost of management.
  
  
  OBJECTIVE
  To compare the cost of the management of ectopic pregnancy by medical treatment (methotrexate, MTX) and coeliochirurgicaux.
  
  
  METHODS
  This is a prospective, comparative, nonrandomized,unicentric study, on 39 patients who have ectopic pregnancies treated with MTX versus 16 patients treated by laparoscopic surgery with conservative treatment. This study was collected at the service of Obstetrics and Gynecology Reproductive Medicine Aziza Othmana Hospital (Tunis) for a period of two years.
  
  
  RESULTS
  The average cost of hospital stay per patient was 549.38 dt for the MTX group against 268.39 dt for laparoscopic surgery group (p <0.001). There was no statistically significant difference between the two groups. In terms of overall absenteeism, there is no statistically significant difference (16.43 vs 17.5 days).
  
  
  CONCLUSIONS
  The initial treatment with MTX costs more cost than the conservative laparoscopic treatment and this is mainly due to the long period of hospitalization.
authors.affiliation: Service de Gynecologie Obstetrique et de Medeci e de la Reproduction, Hopital Aziza Othmana, Tunisie.
authors.forename: Anis
authors.initials: A
authors.lastname: Fadhlaoui
authors.forename: Hanene
authors.initials: H
authors.lastname: Oueslati
authors.forename: Zied
authors.initials: Z
authors.lastname: Khedhiri
authors.forename: Mohamed
authors.initials: M
authors.lastname: Khrouf
authors.forename: Anis
authors.initials: A
authors.lastname: Chaker
authors.forename: Fethi
authors.initials: F
authors.lastname: Zhioua
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000191:economics / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006760:Hospitalization / Q000191:economics; D006801:Humans; D010535:Laparoscopy / Q000191:economics; D008727:Methotrexate / Q000191:economics / Q000627:therapeutic use*; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000191:economics* / Q000628:therapy*; D011446:Prospective Studies; D014416:Tunisia; D055815:Young Adult
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D008727:Methotrexate